| Yuhan | Approved | $6474.6B | Oncology, Metabolic Diseases |
| Cipla | Commercial | $1088.1B | Respiratory, Oncology |
| Sumitomo Pharma | Launched | $640.8B | Psychiatry, Oncology |
| Biocon | Commercial | $616.0B | Oncology, Immunology |
| Shinpoong Pharm | Marketed | $590.0B | Infectious Diseases, Malaria |
| KOBAYASHI Pharmaceutical | Market | $439.0B | Dermatology, Gastrointestinal |
| Gland Pharma | Commercial | $313.8B | Anti-infectives, Cardiology |
| Piramal Pharma | Commercial | $238.3B | Critical Care, Ophthalmology |
| Hansoh Pharma | Approved | $219.7B | Oncology, Central Nervous System Disorders |
| Natco Pharma | Launched | $210.4B | Oncology, Hepatology |
| Kissei Pharmaceutical | Marketed | $181.1B | Urology, Nephrology |
| GSK plc | Commercial | $100.7B | Respiratory, Immunology and Inflammation, Oncology |
| FDC India | Commercial | $61.9B | Gastroenterology, Vitamins & Minerals |
| Huadong Medicine (HD Medicine) | NDA Submitted | $58.3B | Oncology, Autoimmune Diseases |
| Edwards Lifesciences | Commercial | $46.8B | Cardiovascular, Structural Heart Disease |
| Guangzhou Baiyunshan Pharmaceutical Holdings | Commercial | $37.0B | Oncology, Cardiovascular & Metabolic |
| PharmaMar | Commercial | $22.1B | Oncology |
| Joincare Pharmaceutical Group Industry Co. | commercial | $19.7B | Cardiovascular, Respiratory |
| Smith and Nephew | Commercial | $12.8B | Orthopedics, Sports Medicine |
| Recordati | Commercial | $10.2B | Rare Diseases, Cardiology |
| Grifols | Commercial | $5.5B | Immunology, Hematology |
| Siegfried Holding | Commercial | $3.6B | — |
| Ligand Pharmaceuticals | Marketed | $2.5B | Oncology, Metabolic Disorders |
| Vetoquinol | Launched | $860.2M | Companion Animal Health, Livestock Health |
| Tilray | Phase 3 | $662.0M | Oncology, Neurology |
| Moberg Pharma | Marketed | $79.6M | Dermatology, Infectious Disease |
| InterCure | Marketed | $47.3M | Chronic Pain, Oncology Supportive Care |
| NGM Biopharmaceuticals | Phase 2 | — | Oncology, Metabolic |
| Carmat | Market Approved (CE Mark) / Pivotal Trial (U.S.) | — | Cardiovascular |
| Vapotherm | Commercial | — | Respiratory Failure, COPD |
| Medicilon | platform | — | Oncology, Autoimmune Diseases |
| Mabwell Biotech | phase-2 | — | Oncology, Autoimmune Diseases |
| Luye Pharma | commercial | — | Neuroscience, Oncology |
| Henlius Biopharmaceuticals | commercial | — | Oncology, Immunology |
| Green Valley Pharmaceuticals | commercial | — | Neuroscience |
| Eddingpharm | commercial | — | Oncology |
| SNIBE Diagnostics | commercial | — | Diagnostics |
| Syneron Bio | commercial | — | Dermatology, Aesthetic Medicine |
| Zydus Cadila | commercial | — | Oncology, Cardiovascular |
| Boan Biotech | commercial | — | Oncology, Immunology |
| Aosaikang Pharmaceutical | phase-2 | — | Oncology, Metabolic Diseases |
| Shandong Luoxin Pharmaceutical | commercial | — | Oncology, Cardiovascular |
| Chia Tai TianQing Pharmaceutical Group | commercial | — | Oncology, Metabolic Diseases |
| Qilu Pharmaceutical | commercial | — | Oncology |
| Kexing Biopharm | commercial | — | Infectious Disease |
| Bloomage Biotech | commercial | — | Medical Aesthetics, Ophthalmology |
| Viva Biotech | platform | — | Oncology, Infectious Disease |
| Sino Biopharmaceutical | commercial | — | Oncology, Hepatology |
| galderma | Market | — | Dermatology, Aesthetic Medicine |
| Essex Bio | commercial | — | Ophthalmology |
| China Medical Systems | commercial | — | Dermatology, Ophthalmology |
| Zylox-Tonbridge | commercial | — | Neuroscience, Cardiovascular Diseases |
| Sinopep | commercial | — | Metabolic |
| Huadong Medicine | commercial | — | Oncology, Metabolic |
| Medipost | commercial | — | Regenerative Medicine, Orthopedics |
| Daan Gene | commercial | — | Infectious Disease, Genetics & Genomics |
| Bio-Thera Solutions | commercial | — | Oncology, Immunology |
| Baird Medical | commercial | — | Oncology |
| Taisho Pharmaceutical | commercial | — | Respiratory, Metabolic |
| Porton Pharma Solutions | platform | — | CDMO Services |
| Respirent Pharmaceuticals Co | commercial | — | Respiratory |
| Maccura Biotechnology | commercial | — | Diagnostics |
| HitGen | platform | — | Oncology, Immunology |
| Chengdu Kanghong Pharmaceutical Group | commercial | — | Ophthalmology, Medical Devices |
| Sansure Biotech | commercial | — | Diagnostics, Infectious Disease |
| Dirui Industrial | commercial | — | Diagnostics |
| Yabao Pharmaceutical | commercial | — | Multiple (Small Molecules) |
| Acotec | commercial | — | Cardiovascular |
| Schrödinger, Inc. | platform | — | Oncology, Immunology |